Menu
中文Book a checkup
NTUH Hsin-Chu Branch Health Management Center · Hsinchu · Medical center

Premium Cardiac Protection Checkup

US$1,988
NT$63,800 · you pay the hospital in NT$

Women: US$2,112 (NT$67,800). The price above is for men.

Book this checkup

Prefer to book it yourself? Call NTUH Hsin-Chu Branch on (03)6677600 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-22

An executive-tier program with Coronary CT angiography, Low-dose chest CT, Abdominal ultrasound, Carotid ultrasound and Pelvic (gynecologic) ultrasound and a 66-test panel.

Fasting
8 hours before
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Coronary CT angiography

Narrowing of the heart arteries without a catheter.

Low-dose chest CT

Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.

Abdominal ultrasound

Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.

Carotid ultrasound

Plaque in the neck arteries; stroke risk.

Every test, in English

66 tests listed, 54 of them on our shared test list, so they line up against other hospitals' packages.

Vitals4
Blood Count3
Liver Function4
Kidney & Electrolytes4
Lipids & Cardiometabolic6
Glucose3
Thyroid & Endocrine4
Tumor Markers9
Urine & Stool1
Cardiac4
Ultrasound4
CT Imaging2
Women's Health2
Bone & Body Composition1
Eye3
Show all 66 tests and what each screens for
TestScreens for
Vitals
Blood pressureScreens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysisBody fat, muscle mass and water percentage.
Basic vital signs (pulse, temperature, respiration)Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumferenceCentral obesity, a marker of metabolic risk.
Blood Count
Complete blood countAnemia, infection and blood cell disorders.
Rheumatoid factor (RF)A marker associated with rheumatoid arthritis.
White blood cell differentialBreakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
Alkaline phosphataseLiver, bile duct and bone conditions.
ALT (SGPT)Liver cell damage; the most common liver screening test.
AST (SGOT)Liver cell damage.
Gamma-GTBile duct and alcohol-related liver stress.
Kidney & Electrolytes
Blood urea nitrogenKidney function.
CreatinineKidney function.
Estimated GFRKidney filtering capacity; stages chronic kidney disease.
Uric acidGout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterolProtective cholesterol level.
HomocysteineCardiovascular risk marker.
High-sensitivity CRPInflammation linked to heart disease risk.
LDL cholesterolThe main cholesterol driving heart disease risk.
Total cholesterolCardiovascular risk.
TriglyceridesCardiovascular and pancreatitis risk.
Glucose
Fasting glucoseDiabetes and prediabetes.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.
Fasting insulinInsulin resistance.
Thyroid & Endocrine
Free T4Thyroid hormone level.
TestosteroneMale hormone level; low testosterone.
TSHThyroid function; the primary thyroid screening test.
Vitamin D (25-OH)Vitamin D deficiency; bone health.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125Ovarian cancer marker.
CA 15-3Breast cancer marker.
CA 19-9Pancreatic and biliary cancer marker.
CEAColorectal and other GI cancer marker.
CYFRA 21-1Lung cancer marker.
EBV VCA-IgANasopharyngeal cancer risk (common in Taiwan and southern China).
NSESmall cell lung cancer and neuroendocrine tumor marker.
SCC antigenSquamous cell cancer marker (cervix, lung, head and neck).
Urine & Stool
Stool occult blood (FIT)Colorectal cancer and polyps; the standard non-invasive colon screen.
Cardiac
Arterial stiffness (ABI / PWV)Peripheral artery disease and arterial stiffness.
EchocardiogramHeart structure, valves and pumping function.
NT-proBNPHeart failure and heart strain.
Resting ECGHeart rhythm and signs of prior heart damage.
Ultrasound
Abdominal ultrasoundLiver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Carotid ultrasoundPlaque in the neck arteries; stroke risk.
Pelvic (gynecologic) ultrasoundUterus and ovary abnormalities (fibroids, cysts).
Thyroid ultrasoundThyroid nodules.
CT Imaging
Coronary CT angiographyNarrowing of the heart arteries without a catheter.
Low-dose chest CTEarly lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
Women's Health
HPV DNA testHigh-risk HPV strains that cause cervical cancer.
MammographyBreast cancer; the standard screen for women 40+.
Bone & Body Composition
Bone density (DXA)Osteoporosis and fracture risk.
Eye
Color visionColor vision deficiency.
Intraocular pressureGlaucoma.
Visual acuityVision sharpness.
Vitals
Blood pressure
Screens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysis
Body fat, muscle mass and water percentage.
Basic vital signs (pulse, temperature, respiration)
Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumference
Central obesity, a marker of metabolic risk.
Blood Count
Complete blood count
Anemia, infection and blood cell disorders.
Rheumatoid factor (RF)
A marker associated with rheumatoid arthritis.
White blood cell differential
Breakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
Alkaline phosphatase
Liver, bile duct and bone conditions.
ALT (SGPT)
Liver cell damage; the most common liver screening test.
AST (SGOT)
Liver cell damage.
Gamma-GT
Bile duct and alcohol-related liver stress.
Kidney & Electrolytes
Blood urea nitrogen
Kidney function.
Creatinine
Kidney function.
Estimated GFR
Kidney filtering capacity; stages chronic kidney disease.
Uric acid
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterol
Protective cholesterol level.
Homocysteine
Cardiovascular risk marker.
High-sensitivity CRP
Inflammation linked to heart disease risk.
LDL cholesterol
The main cholesterol driving heart disease risk.
Total cholesterol
Cardiovascular risk.
Triglycerides
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose
Diabetes and prediabetes.
Hemoglobin A1c
Average blood sugar over the past three months; diabetes.
Fasting insulin
Insulin resistance.
Thyroid & Endocrine
Free T4
Thyroid hormone level.
Testosterone
Male hormone level; low testosterone.
TSH
Thyroid function; the primary thyroid screening test.
Vitamin D (25-OH)
Vitamin D deficiency; bone health.
Tumor Markers
AFP
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125
Ovarian cancer marker.
CA 15-3
Breast cancer marker.
CA 19-9
Pancreatic and biliary cancer marker.
CEA
Colorectal and other GI cancer marker.
CYFRA 21-1
Lung cancer marker.
EBV VCA-IgA
Nasopharyngeal cancer risk (common in Taiwan and southern China).
NSE
Small cell lung cancer and neuroendocrine tumor marker.
SCC antigen
Squamous cell cancer marker (cervix, lung, head and neck).
Urine & Stool
Stool occult blood (FIT)
Colorectal cancer and polyps; the standard non-invasive colon screen.
Cardiac
Arterial stiffness (ABI / PWV)
Peripheral artery disease and arterial stiffness.
Echocardiogram
Heart structure, valves and pumping function.
NT-proBNP
Heart failure and heart strain.
Resting ECG
Heart rhythm and signs of prior heart damage.
Ultrasound
Abdominal ultrasound
Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Carotid ultrasound
Plaque in the neck arteries; stroke risk.
Pelvic (gynecologic) ultrasound
Uterus and ovary abnormalities (fibroids, cysts).
Thyroid ultrasound
Thyroid nodules.
CT Imaging
Coronary CT angiography
Narrowing of the heart arteries without a catheter.
Low-dose chest CT
Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
Women's Health
HPV DNA test
High-risk HPV strains that cause cervical cancer.
Mammography
Breast cancer; the standard screen for women 40+.
Bone & Body Composition
Bone density (DXA)
Osteoporosis and fracture risk.
Eye
Color vision
Color vision deficiency.
Intraocular pressure
Glaucoma.
Visual acuity
Vision sharpness.
Also listed: 10-year cardiovascular disease risk score, AMH (anti-Mullerian hormone), Beta-hCG, Bilirubin, Cardiac enzymes, H. pylori urea breath test (C-13), Lipoprotein(a), Liquid-based Pap smear, Physician examination and preliminary report review, Prostate Health Index (PHI), Urine chemistry panel, Urine sediment examination.

Before you book

Fasting8 hours before
AgeeGFR not applicable under 18 or over 70 (source note)
If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
NTUH Hsin-Chu Branch Health Management Center
Medical center
Hsinchu · North

About 12 minutes' walk (880 m) from North Hsinchu station

5 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment

  • The Zhubei campus health management center's self-pay checkups run Monday to Friday, 8:00 to 12:00.

    Source ↗ · checked 2026-09-22

  • The main Hsinchu campus's Zhiyu Hall (6F) half-day and full-day checkups run Monday to Friday, 8:00 to 11:00.

    Source ↗ · checked 2026-09-22

  • The center says same-day on-site add-ons or changes to the checkup package are not available; any change to the package or add-on items must be requested at least two weeks before the exam date.

    Source ↗ · checked 2026-09-22

Before and on the day

  • The Zhubei campus center asks female patients to confirm before the checkup whether they are pregnant and to tell the center if so.

    Source ↗ · checked 2026-09-22

  • The center asks patients to fast completely, including water, for 8 hours before the blood draw.

    Source ↗ · checked 2026-09-22

  • The center asks patients to avoid staying up late, drinking alcohol and strenuous exercise for 2 days before the blood draw.

    Source ↗ · checked 2026-09-22

  • The center asks patients to collect a mid-stream urine sample for the urine test.

    Source ↗ · checked 2026-09-22

  • The center asks patients who are menstruating to tell registration staff and to provide the urine sample after their period ends.

    Source ↗ · checked 2026-09-22

  • The center asks patients to fast, including water and medication, from midnight the night before the exam.

    Source ↗ · checked 2026-09-22

  • The center asks female patients not to wear a one-piece dress or shapewear on the day of the exam, to make the exam easier.

    Source ↗ · checked 2026-09-22

  • The center asks patients to wear loose clothing for the exam, and asks female patients not to wear a one-piece outfit or tights.

    Source ↗ · checked 2026-09-22

  • The center asks patients not to wear clothing with metal buttons or sequins for the X-ray and to remove necklaces and ID badges; female patients are advised to wear a wireless sports bra rather than one with metal clasps.

    Source ↗ · checked 2026-09-22

  • The center says patients who are or may be pregnant cannot have the X-ray and should tell the reception staff.

    Source ↗ · checked 2026-09-22

Results

  • All six Zhubei campus checkup packages include a physician's physical exam with an explanation of the preliminary report.

    Source ↗ · checked 2026-09-22

  • The center provides Chinese reports by default; patients must actively request an English report, which costs extra.

    Source ↗ · checked 2026-09-22

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$4,077–5,946 for a woman (51 of 54 tests) and US$3,435–5,092 for a man (46 of 49 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 6.9 mSv from the tests we could identify, a typical adult dose for these exams: roughly 2.3 years of natural background radiation (about 3 mSv a year, US average).

This package also lists 12 items we have not matched to a test; if any of them is an X-ray, CT or PET scan, the total is higher.

  • Bone density (DXA) · about less than 0.01 mSv
  • Coronary CT angiography · about 5.1 mSv
  • Low-dose chest CT · about 1.5 mSv
  • Mammography · about 0.28 mSv

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 23 of these tests
Arterial stiffness (ABI / PWV)
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding the ankle-brachial index to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement that is limited to coronary artery calcium scoring; its September 2024 research plan excludes the ABI, which it says will be evaluated as a screening test in a separate future topic on peripheral artery disease.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for peripheral artery disease and cardiovascular disease risk with the ankle-brachial index in asymptomatic adults. (2018) · USPSTF ↗ Note: A separate statement from the nontraditional-risk-factor one; see the other abi_pwv row. Neither USPSTF statement mapped here addresses pulse wave velocity (arterial stiffness).
Blood pressure
Recommended (grade A/B)The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, confirmed with measurement outside the clinical setting before starting treatment. (2021) · USPSTF ↗
Bone density (DXA)
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗
CA-125
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
CA 19-9
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Carotid ultrasound
Recommended against (grade D)The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population. (2021) · USPSTF ↗
Fasting glucose
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Free T4
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Hemoglobin A1c
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
HDL cholesterol
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
HPV DNA test
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women younger than 21 years. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (CIN 2 or 3) or cervical cancer. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer in women aged 30 to 65 years with high-risk HPV testing every 5 years, alone or combined with cytology, as an alternative to cytology alone. (2018; an update is in progress) · USPSTF ↗ Note: For women aged 21 to 29 the 2018 statement recommends cytology alone every 3 years, not HPV testing. A draft update posted December 10, 2024 proposes primary HPV testing every 5 years (clinician- or patient-collected) for ages 30 to 65, with cytology every 3 years or cotesting every 5 years as alternatives; not yet a final USPSTF recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior negative screening and are not otherwise at high risk. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.
High-sensitivity CRP
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding high-sensitivity CRP to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement, but the key questions in its research plan cover coronary artery calcium scoring only, not hs-CRP.
Intraocular pressure
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Low-dose chest CT
Recommended (grade A/B)The USPSTF recommends annual screening for lung cancer with low-dose CT in adults aged 50 to 80 years with a 20 pack-year smoking history who currently smoke or quit within the past 15 years. (2021) · USPSTF ↗ Note: Screening should stop once the person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability to have curative lung surgery.
Mammography
Recommended (grade A/B)The USPSTF recommends biennial screening mammography for women aged 40 to 74 years. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening mammography in women 75 years or older. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Pelvic (gynecologic) ultrasound
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.
Resting ECG
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Stool occult blood (FIT)
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT). (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT). (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Selective (grade C)The USPSTF recommends that clinicians selectively offer colorectal cancer screening, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT), to adults aged 76 to 85 years based on overall health, prior screening history and the patient's preferences. (2021) · USPSTF ↗ Note: Grade C reflects an individual decision rather than a blanket recommendation for or against. Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Thyroid ultrasound
Recommended against (grade D)The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. (2017) · USPSTF ↗
Total cholesterol
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
TSH
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Visual acuity
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for impaired visual acuity in older adults. (2022) · USPSTF ↗
Vitamin D (25-OH)
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (2021) · USPSTF ↗
General preparation notes for 13 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Body composition analysis

Mention when booking: Mention a pacemaker or implanted defibrillator: the test passes a weak electric current through the body and has traditionally not been recommended with these devices.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Fasting insulin

Usually needs 8 to 12 hours of fasting (no food or drink except plain water) beforehand.

Mention when booking: Mention biotin (vitamin B7) supplements, usually paused for at least a day before this test, and any diabetes medicine; ask the prescribing doctor before changing any medicine.

Stool occult blood (FIT)

Guaiac-based kits usually ask you to avoid red meat, NSAIDs and more than 250mg of vitamin C for a few days beforehand; FIT kits usually need no diet change.

Mention when booking: Tell the center which kit you were given, and ask the prescribing doctor before stopping aspirin taken for the heart.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Coronary CT angiography

Usually needs 3 to 4 hours without food and no caffeine beforehand, since caffeine makes it harder to slow the heart for clear pictures; water is often still allowed. Erectile-dysfunction medicines are avoided.

Mention when booking: Mention recent erectile-dysfunction medicine (nitroglycerin is often given), asthma, kidney disease, contrast allergy, metformin or pregnancy; ask the prescribing doctor before changing any medicine.

Low-dose chest CT

Usually needs no fasting and no contrast injection; loose clothing with no metal is easiest.

Mention when booking: Tell the center if you are, or might be, pregnant.

HPV DNA test

Usually needs no special preparation; if combined with a Pap test, avoiding sex, douching and vaginal products for 2 days beforehand is common.

Mention when booking: Tell the center if you are menstruating or had recent intercourse; the test can usually still be done.

Afterwards: Light spotting afterward is common and usually stops within a few hours.

Mammography

Usually asks that you skip deodorant, powder or lotion on the underarms and breasts, since these can look like calcium spots on the image. Bring prior mammograms from elsewhere if you have them.

Mention when booking: Mention breast implants, any breast symptoms, prior breast surgery, hormone use, or the possibility of pregnancy.

Afterwards: You may be asked to wait until the radiologist confirms the images are complete; ask when to expect results.

Bone density (DXA)

Usually asks that you skip calcium supplements for 24 hours beforehand. Avoid clothing with metal zippers or buttons, and remove jewelry.

Mention when booking: Mention any recent barium exam or CT/nuclear-medicine contrast, and whether pregnancy is possible.

Sources
As published by the hospital · checked 2026-09-22

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Package name translated by us from the hospital's Chinese name.
Premium Cardiac Protection Checkup
US$1,988
Book this checkup

If this isn't quite right

Same hospital, cheaper
Premier Brain-Vascular Protection Checkup
NTUH Hsin-Chu Branch Health Management Center
US$1,308
Same focus, Taipei
Elite Program
Taiwan Adventist Hospital Health Management Center
US$1,988

Other packages at NTUH Hsin-Chu Branch

PackageTestsPrice
Guardian Heart-Liver Checkup52
US$841
NT$27,000
Healthy Gut Checkup45
US$841
NT$27,000
Women US$857
Cardiovascular Peace-of-Mind Checkup55
US$1,184
NT$38,000
Women US$1,231
Premier Brain-Vascular Protection Checkup59
US$1,308
NT$42,000
Women US$1,449

All packages at NTUH Hsin-Chu Branch Health Management Center →

Similar packages in Hsinchu

Same tier, other hospitals in Hsinchu, closest in price first.
PackageHospitalTestsPrice
Advanced Imaging Peace-of-Mind Plan - PET + EndoscopyChina Medical University Hsinchu Hospital Health Management Center66
US$1,963
NT$63,000
Lohas Program AHsinchu Mackay Memorial Hospital Health Examination Center60
US$2,025
NT$65,000
Lohas Program BHsinchu Mackay Memorial Hospital Health Examination Center60
US$1,495
NT$48,000

All checkups in Hsinchu →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Cancer screening · Heart and blood vessels · All checkups in Hsinchu · What a checkup costs in Taiwan